Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
07/2012
07/26/2012WO2012061759A3 Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
07/26/2012WO2012061599A3 Vaccines against toxoplasma gondii
07/26/2012WO2012058673A3 Enhanced cancer treatment and monitoring using recombinant vectors
07/26/2012WO2012042279A3 Viral vector immunogenic compositions
07/26/2012WO2012037485A8 Methods of inhibiting alphavirus replication and treating alphavirus infection
07/26/2012WO2012034039A3 Anti-il-1 beta antibodies and methods of use
07/26/2012WO2012031752A3 Tuberculosis mutants
07/26/2012WO2012031273A3 Novel modulators and methods of use
07/26/2012WO2012019268A3 An immunogenic composition for use in a vaccine and an immunodiagnostic test kit for visceral leishmaniasis
07/26/2012WO2011080595A3 Polysaccharide immunogens conjugated to e. coli carrier proteins
07/26/2012US20120192296 Preparation of isolated agonist anti-edar monoclonal antibodies
07/26/2012US20120192295 Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof
07/26/2012US20120192294 Inhibitors of the Nitration of Amyloid Beta Peptides and Their Uses in the Diagnosis and Treatment of Alzheimer's Disease
07/26/2012US20120190975 Nanoparticles for use in tumor diagnosis and therapy
07/26/2012US20120190569 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
07/26/2012US20120189701 Combination therapy with thiocolchicine derivatives
07/26/2012US20120189700 Nanoparticle Based Immunological Stimulation
07/26/2012US20120189664 Cancer stem cell antigen vaccines and methods
07/26/2012US20120189663 Method of producing a medical composition
07/26/2012US20120189662 Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti
07/26/2012US20120189661 Vaccines comprising heat-sensitive transgenes
07/26/2012US20120189659 Attenuated pestiviruses
07/26/2012US20120189658 Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin
07/26/2012US20120189657 Microbial vaccine and vaccine vector
07/26/2012US20120189656 Reverse genetics using non-endogenous pol i promoters
07/26/2012US20120189655 Attenuated Live Vaccine for Prevention of Porcine Reproductive and Respiratory Syndrome
07/26/2012US20120189654 Vaccine
07/26/2012US20120189650 Immunogenic composition comprising variants of staphylococcal clumping factor a
07/26/2012US20120189649 Vaccines and Compositions Against Streptococcus Pneumoniae
07/26/2012US20120189648 Infectious hepatitis c viruses of genotype 3a and 4a and uses thereof
07/26/2012US20120189647 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
07/26/2012US20120189646 Novel compounds
07/26/2012US20120189645 Compositions and methods to treat and control tumors
07/26/2012US20120189644 Anti-mesothelin immunoconjugates and uses therefor
07/26/2012US20120189643 Toll Like Receptor 3 Antagonists, Methods and Uses
07/26/2012US20120189642 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
07/26/2012US20120189641 Combination anti-cancer therapy
07/26/2012US20120189640 Methods and Compositions Related to Soluble Monoclonal Variable Lymphocyte Receptors of Defined Antigen Specificity
07/26/2012US20120189639 Anti-gitr antibodies
07/26/2012US20120189638 Method of treating neurodegenerative disease
07/26/2012US20120189637 Methods for treating psoriasis
07/26/2012US20120189636 Human serum amyloid-a3 antibody and use thereof
07/26/2012US20120189635 Methods for Treating or Preventing Malaria by Administering an Antibody that Specifically Binds Angiopoietin-2 (Ang-2)
07/26/2012US20120189634 Taci as an anti-tumor agent
07/26/2012US20120189633 Anti-kit antibodies and uses thereof
07/26/2012US20120189632 Method for extending pregnancy in patients exhibiting at least one symptom of preeclampsia and eclampsia
07/26/2012US20120189631 Pharmaceutical composition for treating ischemic events
07/26/2012US20120189630 BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES
07/26/2012US20120189629 Anti-il-6 antibodies for the treatment of oral mucositis
07/26/2012US20120189628 Anti-il-tif antibodies and methods of using in inflammation
07/26/2012US20120189627 Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses
07/26/2012US20120189626 Treatment of complement-associated disorders
07/26/2012US20120189625 Compositions and Methods for Treating Hematological Cancers Targeting the SIRPA CD47 Interaction
07/26/2012US20120189624 Treatment and prophylaxis of amyloidosis
07/26/2012US20120189623 Cyclized derivatives as eg-5 inhibitors
07/26/2012US20120189622 Anti-cd38 human antibodies and uses thereof
07/26/2012US20120189621 Combination Therapies and Methods Using Anti-CD3 Modulating Agents and Anti-IL-6 Antagonists
07/26/2012US20120189620 Methods for treating non-functioning pituitary adenoma
07/26/2012US20120189619 Methods for treating a spinal disorder or osteoarthritis using dominant negative tissue necrosis factor
07/26/2012US20120189618 Superior efficacy of cd37 antibodies in cll blood samples
07/26/2012US20120189617 Anti-tim-3 antibody
07/26/2012US20120189616 Isosorbide nitrates
07/26/2012US20120189615 CROSS-ß STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS-ß STRUCTURE, FOR MODULATING CROSS-ß STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS-ß STRUCTURE-MEDIATED TOXICITY
07/26/2012US20120189614 Inhibitors of filovirus entry into host cells
07/26/2012US20120189613 Stim2-mediated capacitive calcium entry
07/26/2012US20120189612 Compositions and methods for treating cancer while preventing or reducing cardiotoxicity and/or cardiomyopathy
07/26/2012US20120189576 3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)
07/26/2012US20120189572 Vaccines targeting cellular death receptors
07/26/2012US20120189542 Anti-CD19 Antibodies
07/26/2012US20120189541 Dual Variable Domain Immunnoglobulins and Uses Thereof
07/26/2012US20120189540 IL3Ralpha Antibody Conjugates And Uses Thereof
07/26/2012US20120189537 Nitrile derivatives and their pharmaceutical use and compositions
07/26/2012CA2861313A1 Vaccines and compositions against streptococcus pneumoniae
07/26/2012CA2825094A1 Pvrl4 (nectin 4) is a receptor for measles virus
07/26/2012CA2824885A1 Binding proteins to inhibitors of coagulation factors
07/25/2012EP2479270A1 Gene expressing a bifidobacterium surface-presented fusion protein
07/25/2012EP2479187A1 Genes encoding major capsid protein L1 of human papilloma viruses
07/25/2012EP2479186A1 Genes encoding major capsid protein L1 of human papilloma viruses
07/25/2012EP2479184A2 Beta immunogenic peptide carrier conjugates and methods of producing the same
07/25/2012EP2478917A1 SP35 antibodies and uses thereof
07/25/2012EP2478916A1 Influenza vaccines containing hemagglutinin and matrix proteins
07/25/2012EP2478915A1 CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses
07/25/2012EP2478913A1 Synthetic HLA binding peptide analogues and uses thereof
07/25/2012EP2478912A1 Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy
07/25/2012EP2478911A1 Method for treating Parkinson's disease using filamentous bacteriophage
07/25/2012EP2478110A1 Class i anti-cea antibodies and uses thereof
07/25/2012EP2478103A2 Lassa virus-like particles and methods of production thereof
07/25/2012EP2478003A1 Hair growth methods using fgfr4 extracellular domains
07/25/2012EP2477659A1 Vaccines and immunotherapeutics comprising il-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same
07/25/2012EP2477658A2 Hiv-1 antibodies
07/25/2012EP2477656A1 Treatment of neurological conditions
07/25/2012EP2477655A2 Vaccines directed to langerhans cells
07/25/2012EP2477654A1 Methods for treating psoriasis
07/25/2012EP2477653A1 Dosage regimen for administering an epcamxcd3 bispecific antibody
07/25/2012EP2477652A1 Immunization strategy to prevent h1n1 infection
07/25/2012EP2477651A1 Immunological compositions for hiv
07/25/2012EP2477650A1 Virus like particles comprising target proteins fused to plant viral coat proteins
07/25/2012EP2477649A1 Vaccine against cholera and enterotoxigenic e. coli (etec) diarrhea
07/25/2012EP2477648A1 Synergistic anti-cd47 therapy for hematologic cancers
07/25/2012EP2477647A1 Modulation of yeast-based immunotherapy products and responses
1 ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 ... 1823